Works matching DE "MELPHALAN"

Results: 559

Do's and Don'ts" for intraarterial chemotherapy for retinoblastoma- What ophthalmologist and interventional radiologist need to know?

Published in:

Indian Journal of Ophthalmology, 2025, v. 73, n. 6, p. 916, doi. 10.4103/IJO.IJO_2912_24

By:

Bhatter, Pallav;
Parthasarathy, Rajsrinivas;
Gupta, Vipul;
Dusa, Srinivas Rao;
Aggarwal, Ujjwal;
Das, Sima;
Kumar, Pallav

Publication type:

Article

Cyclical 10‐day dosing of melphalan for canine multiple myeloma.

Published in:

Veterinary & Comparative Oncology, 2023, v. 21, n. 3, p. 533, doi. 10.1111/vco.12916

By:

Teddy, Lucy;
Sylvester, Skylar R.;
O'Connor, Kelly S.;
Hume, Kelly R.

Publication type:

Article

Evaluation of a multi‐agent chemotherapy protocol combining dexamethasone, melphalan, actinomycin D, and cytarabine for the treatment of resistant canine non‐Hodgkin high‐grade lymphomas: a single centre's experience.

Published in:

Veterinary & Comparative Oncology, 2019, v. 17, n. 2, p. 165, doi. 10.1111/vco.12457

By:

Smallwood, Katherine;
Tanis, Jean‐Benoit;
Grant, Iain A.;
Blackwood, Laura;
Killick, David R.;
Amores‐Fuster, Isabel;
Elliott, James;
Mas, Aran;
Harper, Aaron;
Marrington, Mary;
Finotello, Riccardo

Publication type:

Article

A dexamethasone, melphalan, actinomycin-D and cytarabine chemotherapy protocol as a rescue treatment for feline lymphoma.

Published in:

Veterinary & Comparative Oncology, 2018, v. 16, n. 1, p. E144, doi. 10.1111/vco.12360

By:

Elliott, J.;
Finotello, R.

Publication type:

Article

Oral melphalan for the treatment of relapsed canine lymphoma.

Published in:

Veterinary & Comparative Oncology, 2018, v. 16, n. 1, p. E123, doi. 10.1111/vco.12356

By:

Mastromauro, M. L.;
Suter, S. E.;
Hauck, M. L.;
Hess, P. R.

Publication type:

Article

Potency and stability of compounded formulations of chlorambucil, melphalan and cyclophosphamide.

Published in:

Veterinary & Comparative Oncology, 2017, v. 15, n. 4, p. 1558, doi. 10.1111/vco.12301

By:

Burton, J. H.;
Knych, H. K.;
Stanley, S. D.;
Rebhun, R. B.

Publication type:

Article

Challenges associated with test dose pharmacokinetic predictions of high dose melphalan exposure in patients with multiple myeloma.

Published in:

European Journal of Clinical Pharmacology, 2022, v. 78, n. 12, p. 1911, doi. 10.1007/s00228-022-03396-x

By:

Nath, Christa Ellen;
Grigg, Andrew;
Rosser, Sebastian P. A.;
Estell, Jane;
Newman, Elizabeth;
Tiley, Campbell;
Ramanathan, Sundra;
Ho, Shir Jing;
Larsen, Stephen;
Gibson, John;
Presgrave, Peter;
Shaw, Peter John;
Trotman, Judith

Publication type:

Article

Predicting the presence and mechanism of busulfan drug-drug interactions in hematopoietic stem cell transplantation using pharmacokinetic interaction network–based molecular structure similarity and network pharmacology.

Published in:

European Journal of Clinical Pharmacology, 2021, v. 77, n. 4, p. 595, doi. 10.1007/s00228-020-03034-4

By:

Hao, Chenxia;
Ma, Xiaoqin;
Wang, Lining;
Zhang, Weixia;
Hu, Jiong;
Huang, Jingjing;
Yang, Wanhua

Publication type:

Article

First-line therapy for non-transplant eligible patients with multiple myeloma: direct and adjusted indirect comparison of treatment regimens on the existing market in Germany.

Published in:

European Journal of Clinical Pharmacology, 2016, v. 72, n. 3, p. 257, doi. 10.1007/s00228-015-1998-5

By:

Kuhr, Kathrin;
Wirth, Daniel;
Srivastava, Kunal;
Lehmacher, Walter;
Hellmich, Martin

Publication type:

Article

Clinical and pathomorphological changes in the rabbit retina after an injection of various doses of the cytostatic melphalan.

Published in:

Journal of Ophthalmology (Ukraine) / Oftalʹmologičeskij Žurnal, 2023, n. 5, p. 41, doi. 10.31288/oftalmolzh202354145

By:

Bobrova, N. F.;
Sorochynska, T. A.;
Tronina, S. A.;
Romanova, T. V.;
Molachaniuk, N. I.;
Bratishko, O. Iu.;
Shylyk, A. V.

Publication type:

Article

High-dose intravitreal chemotherapy in the treatment of high-risk retinoblastoma.

Published in:

Journal of Ophthalmology (Ukraine) / Oftalʹmologičeskij Žurnal, 2022, n. 4, p. 23, doi. 10.31288/oftalmolzh202242327

By:

Bobrova, N. F.;
Sorochynska, T. A.;
Tronina, S. A.;
Romanova, T. V.;
Bratishko, O. Yu.

Publication type:

Article

Ultrastructural changes in the rabbit retina after various one-time doses of intravitreal melphalan.

Published in:

Journal of Ophthalmology (Ukraine) / Oftalʹmologičeskij Žurnal, 2020, n. 4, p. 50, doi. 10.31288/oftalmolzh202045055

By:

Bobrova, N. F.;
Sorochynska, T. A.;
Molachaniuk, N. I.;
Bratishko, A. Iu.

Publication type:

Article

FDA Approves Melphalan as a Liver-Directed Treatment for Uveal Melanoma.

Published in:: ONS Voice, 2023, p. 1
Publication type:: Article

Relation of junctional adhesion molecule-a in multiple myeloma patients with possible prognostic factors.

Published in:

Egyptian Journal of Haematology, 2023, v. 48, n. 2, p. 201, doi. 10.4103/ejh.ejh_55_23

By:

Shaaban, Ingy Ossama Ahmed;
Sultan, Hala K.;
Sultan, Magda M.;
El Gammal, Maha M. A.;
Balbaa, Ola A.

Publication type:

Article

Cyclopamine sensitizes multiple myeloma cells to circularly permuted TRAIL-induced apoptosis.

Published in:

Oncology Letters, 2021, v. 21, n. 4, p. N.PAG, doi. 10.3892/ol.2021.12556

By:

Wang, Huijuan;
Geng, Chuanying;
Zhou, Huixing;
Zhang, Zhiyao;
Chen, Wenming

Publication type:

Article

Secondary lymphoblastic leukemia occurring 38 months after the primary diagnosis of multiple myeloma: A case report.

Published in:

2016

By:

JUNXUN LI;
JIEYU ZHAN;
FAN ZHANG;
ZHUANGJIAN YE;
JUAN OUYANG

Publication type:

Case Study

Leukemia cells are sensitized to temozolomide, carmustine and melphalan by the inhibition of O<sup>6</sup>-methylguanine-DNA methyltransferase.

Published in:

Oncology Letters, 2015, v. 10, n. 2, p. 845, doi. 10.3892/ol.2015.3307

By:

HAJIME ARAI;
TAKAHIRO YAMAUCHI;
KANAKO UZUI;
TAKANORI UEDA

Publication type:

Article

The interaction between oral melphalan and gastric antisecretory drugs: Impact on clinical efficacy and toxicity.

Published in:

Molecular & Clinical Oncology, 2016, v. 4, n. 2, p. 293, doi. 10.3892/mco.2015.683

By:

FUMIAKI KITAZAWA;
YOKO KADO;
KUMI UEDA;
TAKATOSHI KOKUFU;
SHIN-ICHI FUCHIDA;
AKIRA OKANO;
MAYUMI HATSUSE;
SATOSHI MURAKAMI;
YUKO NAKAYAMA;
KOHJI TAKARA;
CHIHIRO SHIMAZAKI

Publication type:

Article

Editorial: Immunotherapy in Multiple Myeloma.

Published in:

2019

By:

Giuliani, Nicola;
Malavasi, Fabio

Publication type:

Editorial

Temporal and Spatial Correlation Between Choroidal Thickness and Visual Function in a Case of POEMS Syndrome.

Published in:

2018

By:

González-Martin-Moro, Julio;
Contreras, Inés;
Pilo-de-la-Fuente, Belén;
Gómez-Sanz, Fernando

Publication type:

journal article

High-dose chemotherapy and autologous stem cell transplantation with melphalan, etoposide and carboplatin for high-risk osteosarcoma.

Published in:

Bone Marrow Transplantation, 2015, v. 50, n. 10, p. 1375, doi. 10.1038/bmt.2015.145

By:

Hong, C R;
Kang, H J;
Kim, M S;
Ju, H Y;
Lee, J W;
Kim, H;
Kim, H-S;
Park, S-H;
Park, K D;
Park, J D;
Shin, H Y;
Ahn, H S

Publication type:

Article

Validation of a new integrated prognostic score to predict non-relapse mortality in patients undergoing reduced-intensity conditioning allogeneic hematopoietic cell transplantation.

Published in:

Bone Marrow Transplantation, 2015, v. 50, n. 10, p. 1371, doi. 10.1038/bmt.2015.144

By:

Barba, P;
Martino, R;
Orti, G;
Esquirol, A;
Perez-Hoyos, S;
Sierra, J;
Valcárcel, D

Publication type:

Article

Re-invigorating rather than re-inventing the wheel: augmenting the impact of salvage autologous stem cell transplantation for multiple myeloma in the era of novel agents.

Published in:

Bone Marrow Transplantation, 2015, v. 50, n. 10, p. 1269, doi. 10.1038/bmt.2015.175

By:

Cook, G

Publication type:

Article

Salvage bortezomib-dexamethasone and high-dose melphalan (HDM) and autologous stem cell support (ASCT) in myeloma patients at first relapse after HDM with ASCT. A phase-2 trial.

Published in:

Bone Marrow Transplantation, 2015, v. 50, n. 10, p. 1306, doi. 10.1038/bmt.2015.125

By:

Gimsing, P;
Hjertner, Ø;
Abildgaard, N;
Andersen, N F;
Dahl, T G;
Gregersen, H;
Klausen, T W;
Mellqvist, U-H;
Linder, O;
Lindås, R;
Tøffner Clausen, N;
Lenhoff, S

Publication type:

Article

Tandem high-dose chemotherapy strategy as first-line treatment of primary disseminated multifocal Ewing sarcomas in children, adolescents and young adults.

Published in:

Bone Marrow Transplantation, 2015, v. 50, n. 8, p. 1083, doi. 10.1038/bmt.2015.118

By:

Loschi, S;
Dufour, C;
Oberlin, O;
Goma, G;
Valteau-Couanet, D;
Gaspar, N

Publication type:

Article

High-dose melphalan with autologous stem cell support in refractory Hodgkin lymphoma patients as a bridge to second transplant.

Published in:

Bone Marrow Transplantation, 2015, v. 50, n. 4, p. 499, doi. 10.1038/bmt.2014.304

By:

Castagna, L;
Crocchiolo, R;
Giordano, L;
Bramanti, S;
Carlo-Stella, C;
Sarina, B;
Chiti, A;
Mauro, E;
Gandolfi, S;
Todisco, E;
Balzarotti, M;
Anastasia, A;
Magagnoli, M;
Brusamolino, E;
Santoro, A

Publication type:

Article

Inadvertent transmission of occult CML through allo-SCT.

Published in:

Bone Marrow Transplantation, 2015, v. 50, n. 4, p. 598, doi. 10.1038/bmt.2014.294

By:

de Brito, M D;
Campilho, F;
Branca, R;
Vaz, C P;
Campos, A

Publication type:

Article

Outcome of children with high-risk acute myeloid leukemia given autologous or allogeneic hematopoietic cell transplantation in the aieop AML-2002/01 study.

Published in:

Bone Marrow Transplantation, 2015, v. 50, n. 2, p. 181, doi. 10.1038/bmt.2014.246

By:

Locatelli, F;
Masetti, R;
Rondelli, R;
Zecca, M;
Fagioli, F;
Rovelli, A;
Messina, C;
Lanino, E;
Bertaina, A;
Favre, C;
Giorgiani, G;
Ripaldi, M;
Ziino, O;
Palumbo, G;
Pillon, M;
Pession, A;
Rutella, S;
Prete, A

Publication type:

Article

Not too little, not too much-just right! (Better ways to give high dose melphalan).

Published in:

Bone Marrow Transplantation, 2014, v. 49, n. 12, p. 1457, doi. 10.1038/bmt.2014.186

By:

Shaw, P J;
Nath, C E;
Lazarus, H M

Publication type:

Article

A phase II study of V-BEAM as conditioning regimen before second auto-SCT for multiple myeloma.

Published in:

Bone Marrow Transplantation, 2014, v. 49, n. 11, p. 1366, doi. 10.1038/bmt.2014.163

By:

Wang, T-F;
Fiala, M A;
Cashen, A F;
Uy, G L;
Abboud, C N;
Fletcher, T;
Wu, N;
Westervelt, P;
DiPersio, J F;
Stockerl-Goldstein, K E;
Vij, R

Publication type:

Article

Hospital admissions following outpatient administration of high-dose melphalan and autologous SCT for AL amyloidosis.

Published in:

Bone Marrow Transplantation, 2014, v. 49, n. 10, p. 1345, doi. 10.1038/bmt.2014.132

By:

Freeman, B;
Brauneis, D;
Seldin, D C;
Quillen, K;
Sloan, J M;
Renteria, A S;
Shelton, A C;
Teschner, T;
Finn, K T;
Sanchorawala, V

Publication type:

Article

Palifermin reduces infection rate and hyperfibrinogenemia in patients treated with high-dose chemotherapy based on beam or BU-thiothepa.

Published in:

Bone Marrow Transplantation, 2014, v. 49, n. 9, p. 1193, doi. 10.1038/bmt.2014.140

By:

Milone, G;
Leotta, S;
Cupri, A;
Fauci, A L;
Spina, P;
Parisi, M;
Berritta, D;
Tripepi, G

Publication type:

Article

Auto-SCT improves survival in systemic light chain amyloidosis: a retrospective analysis with 14-year follow-up.

Published in:

Bone Marrow Transplantation, 2014, v. 49, n. 8, p. 1036, doi. 10.1038/bmt.2014.115

By:

Parmar, S;
Kongtim, P;
Champlin, R;
Dinh, Y;
Elgharably, Y;
Wang, M;
Bashir, Q;
Shah, J J;
Shah, N;
Popat, U;
Giralt, S A;
Orlowski, R Z;
Qazilbash, M H

Publication type:

Article

Phase IIa cross-over study of propylene glycol-free melphalan (LGD-353) and alkeran in multiple myeloma autologous transplantation.

Published in:

Bone Marrow Transplantation, 2014, v. 49, n. 8, p. 1042, doi. 10.1038/bmt.2014.120

By:

Aljitawi, O S;
Ganguly, S;
Abhyankar, S H;
Ferree, M;
Marks, R;
Pipkin, J D;
McGuirk, J P

Publication type:

Article

A novel reduced-intensity umbilical cord blood transplantation using a recombinant G-CSF combined with high-dose Ara-C for active myeloid malignancies.

Published in:

Bone Marrow Transplantation, 2014, v. 49, n. 7, p. 955, doi. 10.1038/bmt.2014.66

By:

Gotoh, M;
Yoshizawa, S;
Katagiri, S;
Suguro, T;
Asano, M;
Kitahara, T;
Akahane, D;
Okabe, S;
Tauchi, T;
Ito, Y;
Ohyashiki, K

Publication type:

Article

Outcomes following second allogeneic haematopoietic transplants using fludarabine-melphalan conditioning.

Published in:

Bone Marrow Transplantation, 2014, v. 49, n. 6, p. 852, doi. 10.1038/bmt.2014.23

By:

Bilmon, I;
Nivison-Smith, I;
Hertzberg, M;
Ritchie, D;
Greenwood, M;
Spencer, A;
Kennedy, G;
Bryant, A;
Moore, J

Publication type:

Article

Comparison of 1-day vs 2-day dosing of high-dose melphalan followed by autologous hematopoietic cell transplantation in patients with multiple myeloma.

Published in:

Bone Marrow Transplantation, 2014, v. 49, n. 6, p. 761, doi. 10.1038/bmt.2014.56

By:

Parmar, S R;
Bookout, R;
Shapiro, J F;
Tombleson, R;
Perkins, J;
Kim, J;
Yue, B;
Tomblyn, M;
Alsina, M;
Nishihori, T

Publication type:

Article

Safety and efficacy of high-dose melphalan and auto-SCT in patients with AL amyloidosis and cardiac involvement.

Published in:

Bone Marrow Transplantation, 2014, v. 49, n. 3, p. 434, doi. 10.1038/bmt.2013.192

By:

Girnius, S;
Seldin, D C;
Meier-Ewert, H K;
Sloan, J M;
Quillen, K;
Ruberg, F L;
Berk, J L;
Doros, G;
Sanchorawala, V

Publication type:

Article

Acute GVHD prophylaxis with standard-dose, micro-dose or no MTX after fludarabine/melphalan conditioning.

Published in:

Bone Marrow Transplantation, 2014, v. 49, n. 2, p. 248, doi. 10.1038/bmt.2013.167

By:

Chen, G L;
Zhang, Y;
Hahn, T;
Abrams, S;
Ross, M;
Liu, H;
McCarthy, P L

Publication type:

Article

Favorable impact of pre-transplant ATG on outcomes of reduced-intensity hematopoietic cell transplants from partially mismatched unrelated donors.

Published in:

Bone Marrow Transplantation, 2014, v. 49, n. 2, p. 185, doi. 10.1038/bmt.2013.168

By:

Langston, A A;
Prichard, J M;
Muppidi, S;
Nooka, A;
Lechowicz, M J;
Lonial, S;
Sinha, R;
Graiser, M;
Kaufman, J L;
Khoury, H J;
Flowers, C R;
Waller, E K

Publication type:

Article

High-dose melphalan produces favorable response in a patient with multiple myeloma and coexisting essential thrombocythemia with JAK2 mutation.

Published in:

Bone Marrow Transplantation, 2014, v. 49, n. 1, p. 148, doi. 10.1038/bmt.2013.117

By:

Nishihori, T;
Hassoun, Y;
Zhang, L;
Shain, K;
Alsina, M;
Kharfan-Dabaja, M A

Publication type:

Article

Fludarabine Melphalan reduced-intensity conditioning allotransplanation provides similar disease control in lymphoid and myeloid malignancies: analysis of 344 patients.

Published in:

Bone Marrow Transplantation, 2014, v. 49, n. 1, p. 17, doi. 10.1038/bmt.2013.142

By:

Bryant, A;
Nivison-Smith, I;
Pillai, E S;
Kennedy, G;
Kalff, A;
Ritchie, D;
George, B;
Hertzberg, M;
Patil, S;
Spencer, A;
Fay, K;
Cannell, P;
Berkahn, L;
Doocey, R;
Spearing, R;
Moore, J

Publication type:

Article

Assessment of Effectiveness and Adverse Effect of New Combination Chemotherapy (irinotecan, cisplatin, and dexamethasone) in Relapse and Refractory Hodgkin Lymphoma.

Published in:

International Journal of Hematology-Oncology & Stem Cell Research, 2023, v. 17, n. 3, p. 194

By:

Tabarraee, Mahdi;
Rezaee, Atefeh;
Abolghasemi, Sara;
Ghadiany, Mojtaba;
Ardakani, MariaTavakoli;
Mahdizadeh, Mahshid;
Hamidi, Neda;
Ghasemi, Katayoon

Publication type:

Article

Evaluating the Efficacy of Modified BeEAM (Bendamustine, Etoposide, Cytarabine, Melphalan) Regimen as Conditioning for Autologous Stem Cell Transplantation in Relapsed or Refractory Lymphoma: An Experience from Two Centers of a Developing Country.

Published in:

International Journal of Hematology-Oncology & Stem Cell Research, 2023, v. 17, n. 2, p. 106

By:

Ramzi, Mani;
Vafaie, Elaheh;
Haghighinejad, Hourvash;
Imran, Hashim

Publication type:

Article

Long-Term Remission of Acquired von-Willebrand's Disease and Platelet Dysfunction after High-Dose Melphalan in a Patient with Multiple Myeloma.

Published in:

International Journal of Hematology-Oncology & Stem Cell Research, 2019, v. 13, n. 1, p. 7

By:

Stratmann, Jan;
Gundermann, Stefan;
Geisen, Christof;
Dukat, Alexandra;
Miesbach, Wolfgang

Publication type:

Article

Melphalan Flufenamide (Melflufen): First Approval.

Published in:

Drugs, 2021, v. 81, n. 8, p. 963, doi. 10.1007/s40265-021-01522-0

By:

Dhillon, Sohita

Publication type:

Article

Daratumumab: A Review in Combination Therapy for Transplant-Ineligible Newly Diagnosed Multiple Myeloma.

Published in:

Drugs, 2019, v. 79, n. 4, p. 447, doi. 10.1007/s40265-019-01080-6

By:

Syed, Yahiya Y.

Publication type:

Article

Unresectable Hepatic Metastasis of Uveal Melanoma: Hepatic Chemosaturation with High-Dose Melphalan—Long-Term Overall Survival Negatively Correlates with Tumor Burden.

Published in:

Radiology Research & Practice, 2020, p. 1, doi. 10.1155/2020/5672048

By:

Brüning, R.;
Tiede, M.;
Schneider, M.;
Wohlmuth, P.;
Weilert, H.;
Oldhafer, K.;
Stang, A.

Publication type:

Article

Novel Small Molecular Compound AE-848 Potently Induces Human Multiple Myeloma Cell Apoptosis by Modulating the NF-κB and PI3K/Akt/mTOR Signaling Pathways.

Published in:

OncoTargets & Therapy, 2020, v. 13, p. 13063, doi. 10.2147/OTT.S270090

By:

Xu, Yaqi;
Feng, Xiaoli;
Zhou, Qian;
Jiang, Wen;
Dai, Yibo;
Jiang, Yang;
Liu, Xiaoli;
Li, Shuo;
Wang, Yongjing;
Wang, Fang;
Li, Ai;
Zheng, Chengyun

Publication type:

Article

Comparing efficacy and survivals of initial treatments for elderly patients with newly diagnosed multiple myeloma: a network metaanalysis of randomized controlled trials.

Published in:

OncoTargets & Therapy, 2017, v. 10, p. 121, doi. 10.2147/OTT.S123680

By:

Xiaoping Liu;
Jiarui Chen;
He, Yuncen A.;
Xiangyu Meng;
Kaili Li;
He, Colin K.;
Shangqin Liu

Publication type:

Article